Edition:
United States

Alnylam Pharmaceuticals Inc (ALNY.OQ)

ALNY.OQ on NASDAQ Stock Exchange Global Select Market

80.01USD
15 Oct 2018
Change (% chg)

-- (--)
Prev Close
$80.01
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
294,839
52-wk High
$153.80
52-wk Low
$78.93

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 29.91 -1.627
Mar '18 21.90 -1.420
FY 2017 Dec '17 37.92 -1.479
Sep '17 17.10 -1.339
Jun '17 15.93 -1.344
Mar '17 18.96 -1.247
FY 2016 Dec '16 17.45 -1.316
Sep '16 13.65 -1.214
Jun '16 8.71 -1.054
Mar '16 7.34 -1.208
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 13 25.87 68.41 3.80 57.38
Quarter Ending Mar-19 7 32.23 101.56 7.50 --
Year Ending Dec-18 17 99.93 157.71 55.60 124.97
Year Ending Dec-19 18 202.13 518.29 83.60 334.91
Earnings (per share)
Quarter Ending Dec-18 13 -2.14 -1.73 -2.72 -1.27
Quarter Ending Mar-19 7 -2.00 -1.25 -2.41 --
Year Ending Dec-18 15 -7.18 -6.62 -7.70 -5.30
Year Ending Dec-19 17 -7.39 -5.73 -9.65 -3.42
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 86.20 32.69
P/E High - Last 5 Yrs. -- 290.01 45.21
P/E Low - Last 5 Yrs. -- 90.56 23.82
Beta 2.97 0.93 0.88
Price to Sales (TTM) 170.48 123.88 5.82
Price to Book (MRQ) 10.02 15.34 4.90
Price to Tangible Book (MRQ) 10.02 14.54 6.53
Price to Cash Flow (TTM) -- 70.75 22.98
% Owned Institutions 96.38 13.94 2.14

Dividends

  Company industry sector
Dividend Yield -- 0.34 1.51
Dividend Yield - 5 Year Avg -- 0.24 1.52
Dividend 5 Year Growth Rate -- 2.56 5.38
Payout Ratio(TTM) -- 16.91 43.96

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 82.94 391.55 7.73
Sales (TTM) vs TTM 1 Yr. Ago 120.51 73.89 5.32
Sales - 5 Yr. Growth Rate -10.64 30.83 9.89
EPS (MRQ) vs Qtr. 1 Yr. Ago -27.58 24.83 22.57
EPS (TTM) vs TTM 1 Yr. Ago -20.86 -- --
EPS - 5 Yr. Growth Rate -- 37.95 10.95
Capital Spending - 5 Yr. Growth Rate 118.68 38.70 14.94

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.94 2.25
Current Ratio (MRQ) 8.84 5.32 3.05
LT Debt to Equity (MRQ) 13.36 35.04 12.63
Total Debt to Equity (MRQ) 13.36 36.85 16.96
Interest Coverage (TTM) -- -97.99 37.54

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 40.03 54.92
Gross Margin - 5 Yr. Avg. -- 49.23 52.45
EBITD Margin (TTM) -661.41 -- --
EBITD - 5 Yr. Avg -480.35 -574.53 11.10
Operating Margin (TTM) -680.48 -770.03 4.36
Operating Margin - 5 Yr. Avg. -533.41 -594.78 6.45
Pre-Tax Margin (TTM) -670.81 -731.81 5.41
Pre-Tax Margin - 5 Yr. Avg. -518.10 -600.11 6.89
Net Profit Margin (TTM) -670.81 -732.73 1.68
Net Profit Margin - 5 Yr. Avg. -496.94 -603.07 3.14
Effective Tax Rate (TTM) -- 23.70 23.23
Effective Tax Rate - 5 Yr. Avg. -- 18.84 24.11

Efficiency

  Company industry sector
Revenue/Employee (TTM) 128,399 22,887,281 812,879,200
Net Income/Employee (TTM) -861,313 1,727,321 95,609,515
Receivable Turnover (TTM) 5.30 19.88 5.78
Inventory Turnover (TTM) -- 2.39 3.60
Asset Turnover (TTM) 0.05 0.40 0.92

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -31.44 -0.96 10.94
Return on Assets - 5 Yr. Avg. -31.82 3.30 12.05
Return on Investment (TTM) -33.58 0.73 14.32
Return on Investment - 5 Yr. Avg. -35.07 2.37 15.66
Return on Equity (TTM) -39.86 1.82 16.04
Return on Equity - 5 Yr. Avg. -40.19 3.23 16.92
  1 Year 3 Year 5 Year
Sales % 14.75 -0.01 -10.64
EPS (TTM) % -38.73 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Alnylam Pharmaceuticals Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 66.44 60.70 99 60
13 Week 45.87 38.77 99 64
26 Week 152.83 133.61 99 77
52 Week 238.72 187.09 99 47
YTD 227.59 187.69 99 56
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 92.17%
# of Holders: 455
Total Shares Held: 92,785,345
3 Mo. Net Change: 459,286
# New Positions: 4
# Closed Positions: 3
# Increased Positions: 28
# Reduced Positions: 16
# Net Buyers: 12
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.